LT3-21167-36649
1 vaccination
3 coded responses
6 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 190 / PA
- Registered
- 2022-12-11
- Relationship
- Child or adolescent in my care
- Guardian
- YZ8-20111-00178
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-11-14
Dose 1 — ModernaCo-administered: Flu
-
2022-12-11
Registered in v-safe
-
2022-12-11
Survey response — day 21, dose 1, under 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Seasonal coldMedDRA releases: 2024-11 · check-in free text available
-
2022-12-11
Report sent to call center — day 21, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-12
-
2022-12-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-19
Survey response — day 35, dose 1, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Runny nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-26
- 2023-02-13
-
2023-05-15
Survey response — 6 months, dose 1, under 3MedDRA: Ear infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-05-15
Report sent to call center — 6 months, dose 1, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-05-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-11-14 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-11 | Successful 2022-12-12 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-05-15 | Successful 2023-05-16 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Seasonal cold
Release 12 (Under 3) — day 35, dose 1, under 3
Symptoms: Runny nose and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release